Handwritten prescription errors are worldwide common problem. We investigated the types and extent of prescription errors in three cities of Bangladesh. Total 900 outpatient prescriptions were surveyed following the guidelines of WHO and BNF. Prescription errors in superscription, inscription and subscription were analyzed by Microsoft Excel 2010. About 73% patients visited MBBS and 8% BDS doctors. The male outpatients (55%) were slightly higher than female (45%). Commonly found errors of prescription were in superscription part, i.e. gender (64.33%), age (17.67%) and name (5%) of the patients. In inscription part, most common error was the direction for drug use (42%) followed by the dosage regimens (28%), doses (26%), and dosage forms (12.67%) of the drug. In subscription part, illegible handwriting was most common (46%) followed by the prescribers sign (10.67%) and date (4%). In a single prescription, averagely 3 and maximally 8 drugs were found to be prescribed. Most frequently prescribed drugs were antibiotics (18.25%) followed by antacids (17.45%) and NSAIDs (13.60%). Errors in handwritten prescriptions are the primary causes of treatment failure in Bangladesh. More professional care by the prescribers’ and the inclusion of pharmacists in hospital can only reduce the errors and assure safer health.
Haque MU, Barik SMA, Bashar S, Islam R, Bashar S, Kumar A, Dipon AH, Kona N, Chouduri AU. Errors, omissions and medication patterns of handwritten outpatient prescriptions in Bangladesh: a cross-sectional health survey. J App Pharm Sci, 2016; 6 (06): 042-046.
Year
Month
Cephalosporin-3G, Highly Prescribed Antibiotic to Outpatients in Rajshahi, Bangladesh: Prescription Errors, Carelessness, Irrational Uses are the Triggering Causes of Antibiotic Resistance
Worth of Traditional Herbal System of Medicine for Curing Ailments Prevalent Across the Mountain Region of Uttarakhand, India
Prakash Chandra PhondaniEvaluation of the Pharmaceutical Quality of Different Brands of Ranitidine Tablets Manufactured in Bangladesh: A Pharmaceutical and Public Health Prospective